ロード中...
Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)
INTRODUCTION: The Cancer and Leukemia Group B (CALGB) conducted a multi-center phase II trial to evaluate the efficacy and safety of vatalanib in previously untreated patients with malignant mesothelioma and to evaluate potential biomarkers of disease response (CALGB 30107). METHODS: Treatment consi...
保存先:
| 出版年: | Lung Cancer |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4778731/ https://ncbi.nlm.nih.gov/pubmed/22197613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2011.11.014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|